UiPath Inc. (NYSE:PATH) is one of the Exciting AI Stocks to Watch Right Now. On September 5, RBC Capital analyst Matthew ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.88, with a high estimate of $15.00 and a low estimate of $12.00. Experiencing a 11.9% ...

UiPath PATH, a key player in the robotic process automation (“RPA”) market, is trading at a forward 12-month price-to-sales (P/S) ratio of 4.12X, significantly below the industry average of 5.75X.

UiPath has addressed execution issues from early FY 2025, leading to improved contract execution and new sales compensation plans, driving customer and revenue growth. Organizational restructuring and ...

UiPath is a leading robotic process automation company that aims to automate routine tasks, allowing humans to focus on more complex and creative work. Cathie Wood and Ark research believe "Automation ...

UiPath shares are trading higher Friday after the company reported second quarter results above estimates and raised its ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Omega Healthcare partnered with UiPath to automate medical billing and other administrative tasks. The revenue cycle management company has saved employees hours with its AI document-processing tool.